In prostate cancer, researchers found that lncRNA SNHG3, lncRNA prostate cancer-associated transcript 1 (PCAT1) and lncRNA OIP5-AS1 could affect SLC7A11 mRNA expression through different regulatory mechanisms. Here, PCAT1 is linked to prostate carcinoma.